The relationship between human immunodeficiency virus type 1 (HlI-1) infection and the induction of NF-KB binding activity was examined in a myeloid cell model of HIV-1 infection derived from the PLB-985 cell line. Chronic infection of PLB-985 cells led to increased monocyte-specific surface marker expression, increased c-Jins gene transcription, and morphological alterations consistent with differentiation along the monocytic pathway. PLB-IiB cells displayed a constitutive NF-KB-like binding activity that was distinct from that induced by tumor necrosis factor alpha or phorbol 12-myristate 13-acetate treatment of the parental PLB-985 cell line. This unique DNA binding activity consisted of proteins of 70, 90, and 100 kDa with a high degree of binding specificity for the NF-cB site within the PRDII domain of beta interferon. In this report, we characterize the nature of these proteins and demonstrate that binding of these proteins is also induced following Sendai paramyxovirus infection. The 70-kDa protein corresponds to the NF-KB RelA (p65) subunit, which is activated in response to an acute paramyxovirus infection or a chronic HIV-1 infection. Virus infection does not appear to alter the amount of RelA (p65) or NFKB1 (p50) but rather affects the capacity of IKBa to sequester RelA (p65), therefore leading to constitutive levels of RelA DNA binding activity and to increased levels of NF-KB-dependent gene activity. The virally induced 90-to 100-kDa proteins have a distinct binding specificity for the PRDI domain and an AT-rich sequence but do not cross-react with NF-cB subunit-specific antisera directed against NFKB1 (p1O5 or p50), NFKB2 (plO0 or p52), RelA (p65), or c-rel. DNA binding of the 90-to 100-kDa proteins was not inhibited by recombinant IkBcv/MAD-3 and was resistant to tryptic digestion, suggesting that these proteins may not be NF-KB related. Transient cotransfection experiments demonstrated that RelA and NFKB1 expression maximally stimulated HIV-1 LTR-and NF-KB-dependent reporter genes; differences in NF-KB-like binding activity were also reflected in higher constitutive levels of NF-KB-regulated gene expression in HIV-i-infected myeloid ceUls.
CD4+ cells of the monocyte-macrophage lineage, including myeloid progenitor cells in the bone marrow, can be infected with human immunodeficiency virus type 1 (HIV-1) (14, 53) ; these cells may serve as intracellular reservoirs for virus and contribute to the spread of HIV-1 to peripheral tissues, such as the skin, lungs, brain, and lymph nodes (39) . One of the physiological consequences associated with HIV-1 infection of monocytic cells is altered regulation of inflammatory cytokine production (12, 13, 54) ; alterations in the expression of cytokines in HIV-1-infected myeloid cells may involve either increased or decreased cytokine levels, depending on a number of interrelated variables: the inducing agent, the cell types used in the study, and the state of differentiation of the cells. Conversely, cytokines exert differential effects on HIV-1 gene expression; interleukin-1 (IL-1), IL-3, IL-6, tumor necrosis factor alpha/beta (TNF-a/ P), and granulocyte-monocyte colony-stimulating factor (GM-CSF) have been shown to stimulate HIV-1 replication, whereas alpha/beta interferon (IFN-a/p) decreases HIV-1 activity (49) . Cytokines have also been implicated in the pathogenesis of AIDS-associated malignancies, such as Kaposi's sarcoma and B-cell lymphoma (20) , and may contribute to fever, cachexia, and other clinical symptoms (7, 40) .
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One pathway by which cytokine expression and viral gene expression may be coordinately regulated is through the activation of the NF-KB/rel family of transcription factors (reviewed in references 4, 8, and 9) . NF-KB/rel participates in the activation of many immunoregulatory cytokine genes and cell surface receptors. In addition, several viral enhancers, including those of cytomegalovirus, simian virus 40, and HIV-1, contain NF-KB recognition sites. The consensus recognition site is a decamer (5'-GGGANNYYCC-3') with two pentameric half sites, each of which participates in the recognition and stabilization of the binding of the NF-KB dimer (70) . While constitutive NF-KB binding activity has been detected in mature B cells and monocytes (23, 50) , NF-KB expression is inducible in most cell types by viruses, double-stranded RNA, bacterial lipopolysaccharides, cytokines, phorbol esters, and oxygen radical intermediates (26, 37, 62, 63) . NF-KB was initially described as two subunits, p5O (NFKB1) and p65 (RelA) , that existed in the cytoplasm in a latent form complexed to an inhibitory subunit, IKB. Induction resulted in the release of IKB from pSO-p65 and nuclear translocation of the DNA binding heterodimer (3, 18) .
It is now apparent that NF-KB proteins constitute a family of transcription factors whose genes share homology in the N-terminal DNA binding domain with the c-rel proto-oncogene and with the Drosophila morphogen dorsal (4, 8, 9, 21) . in its C-terminal portion (21, 45, 56) . Recently, an alternatively spliced form of RelA, termed ARelA (p65A), was identified; it inhibits NF-KB binding activity and has a distinct trans-dominant negative effect on transcription (43, 58) . c-rel (p85) is the cellular homolog of v-rel, the transforming gene of the reticuloendotheliosis virus, an avian retrovirus that induces acute fatal lymphoma in young birds (9) . The NFKB2 (plOO, p52, and lyt-10) gene encodes a 100-kDa precursor (plOO) and a 52-kDa product and corresponds to lyt-10, originally identified in a chromosomal translocation associated with B-cell lymphoma (44, 60) . Recently, a 68-kDa protein referred to as relB (I-rel) was cloned; relB appears to form activating heterodimers with the p5O protein (57, 59) .
Multiple ankyrin repeat-containing IKB proteins that regulate cytoplasmic anchoring and nuclear uptake of NF-KB proteins have also been defined (4, 8, 9) : IKBa (MAD-3/pp4O/ RL/IF-1), cloned as an immediate-early gene in monocytes (25) , interacts with high affinity with RelA and inhibits NFKB1 (p5O)-RelA (p65) or NFKB2 (p52)-RelA heterodimers and RelA (p65) homodimers; IKBaL is also capable of interacting with NFKB1 (p5O) and c-rel with low affinity (6) . The association ofIKBat with NF-iB proteins occurs via the nuclear localization sequence, and in the uninduced state, IKB masks the nuclear localization sequence (NLS) to prevent nuclear translocation (6, 29, 31, 72) . Bcl3 (and ABcl3) is the product of a gene associated with the t (14;19) chromosomal translocation in chronic lymphocytic leukemia. Bcl3 specifically inhibits the DNA binding activity of NFKB1 (p5O) or NFKB2 (p52) homodimers (15, 30, 71) . IKB-y is a murine 70-kDa protein derived from the carboxyterminal 607 amino acids of p105 by alternative splicing. This protein inhibits the DNA binding of NFKB1 (pSO)-RelA heterodimers, NFKB1 (p5O) homodimers, and c-rel (27) .
Recently, the p105 precursor itself was shown to inhibit the nuclear translocation of c-rel and ReLA; additionally, p105 generates nuclear RelA-pSO and p5O-c-rel complexes through proteolytic processing (51) .
Several studies have now examined the relationship among HIV-1 infection of myeloid cells, induction of NF-KB binding activity (2, 23, 47, 50, 64) , cellular differentiation (1, 17, 46) , and HIV-1 gene expression (38, 67) . Previously, we established a population of HIV-1-infected myelomonoblastic cells (PLB-IIIB) derived from the PLB-985 cell line (55) . Chronic infection of PLB-985 cells led to increased monocyte-specific surface marker expression, increased c-fins gene transcription, and morphological alterations consistent with differentiation along the monocytic pathway (55) . PLB-IIIB cells displayed a constitutive NFKB-like binding activity consisting of proteins of 70, 90, and 100 kDa with a high degree of binding specificity for the NF-KB site within the PRDII domain of IFN-,B (P2) (55) .
In this report, we characterize the nature of these proteins and demonstrate that the binding of these proteins is also induced following Sendai paramyxovirus infection of PLB-985 cells. The 
MATERIALS AND METHODS
Cell culture and transfections. PLB-985 cells (66) were infected with HIV-1 strain IIIB as previously described by use of supernatants from HIV-1-infected U937 cells to establish the chronically infected PLB-IIIB cell line (55) . PLB-985 and PLB-IIIB cells were maintained in RPMI 1640 (GIBCO, Life Technologies Inc., Grand Island, N.Y.) supplemented with 10% fetal calf serum (Hyclone, Logan, Utah), 2mM L-glutamine, and 20,ug of gentamicin (Schering Canada, Pointe Claire, Quebec, Canada) per ml. Exponentially growing cells were treated as follows, depending on the individual experimental protocol: addition of phorbol 12-myristate 13-acetate (PMA) at a final concentration of 25 ng/ml (Sigma Chemical Co., St. Louis, Mo.); addition of TNF-a at 100 U/ml (Genzyme Inc., Kneeland, Mass.); and priming with IFN-a2 (a gift from Schering Canada) for 4 h at 250 IU/ml and then Sendai virus infection at 1,000 hemagglutination units (HAU)/ml (Sendai virus was a kind gift from Kari Cantell). PLB-985 and PLB-IIIB cells were transfected by the DEAE-dextran procedure as previously described (24) . Cells were induced 24 h later and harvested 36 h following transfection, protein was collected, and protein concentrations were determined by the Bio-Rad protein assay (encoding amino acids 10 to 502 of p105) (32) Procedures for extract preparation were those described previously (35) .
EMSA. Cell extracts (2.5 to 5.0 ,ug) were preincubated with the nonspecific DNA competitor poly(dI-dC) (5 ,ug; Pharmacia) for 10 min on ice in a total volume of 15 to 20 p,l of WCE buffer containing 0.1% Nonidet P40 (35) . Binding activity was assessed with 0.2 ng of 32P-end-labelled probes that corresponded to the PRDII domain of the IFN-3 promoter (5'-GGGAAATTCCGGGAAATFCC-3'), the HIV-1 enhancer (5'-AGGGACT'FlTCCGCTGGGGAC'T'EfCC-3'), and a nonspecific AT-rich oligonucleotide (5'-AAAT'ITTAA ATTAAATIAAAIT1T-3') and that were incubated with extracts for 30 min at room temperature. Protein-DNA complexes were then separated on a 5% native polyacrylamide gel (60:1 cross-link) with Tris-glycine (25 mM Tris, 195 mM glycine [pH 8.5]). In the competition analysis, a 125 M excess of unlabelled oligonucleotide was incubated with WCE for 10 min on ice prior to the addition of the probe. For examination of the individual proteins present in the complex, polyclonal subunit-specific antisera against p5O or p105 (antiserum 1141, N-terminus specific) (51) , RelA (antiserum 1226, C-terminus specific) (51), c-rel (antiserum 265, C-terminus specific) (11), and p52 or plOO (antiserum 1267, N-terminus specific) were used in combination with the electrophoretic mobility shift assay (EMSA). Antisera (1:10) were incubated with WCE (2.5 ,ug) in the presence or absence of a specific competitor peptide (0.1 ,ug/pl) for 20 min at room temperature prior to the addition of poly(dI-dC) and radiolabelled probe as described for the EMSA.
Immunoprecipitation of RelA and IKBo PLB-985 and PLB-IIIB cells were washed with phosphate-buffered saline, resuspended in methionine-free RPMI 1640 for 1 h, and labelled for 3 h with 0.5 mCi of Trans35S label (ICN) per ml. Preparation of cell lysates, preclearing with normal rabbit serum, and immunoprecipitation with specific antibodies were carried out essentially as described previously (51) .
UV cross-linking analysis. UV cross-linking analysis was performed in situ with a bromodeoxyuridine (BrdU)-substituted 32P-labelled P2 probe in a standard mobility shift analysis, scaled up twofold and then continued as previously described (34) .
Tryptic digestion of protein-DNA complexes. Tryptic digestion was performed by incubating recombinant p5O (50 ng) or WCE (5 ,ug) Sendai virus increased complex A formation two-to threefold (Fig. 1, lanes 6 and 7) . The specificity of these complexes for the NF-KB site was demonstrated previously in competition and binding site mutagenesis studies (55) . Complex A was also detected within 5 days of de novo HIV-1 infection in PLB-985 cells (data not shown). Similar NF-KB complexes were obtained when the HIV-1 enhancer was used as a probe (55; see also Fig. 2C, lanes 1 and 6) . Thus, distinct NF-KB-related activities observed in HIV-1-infected cells were induced not only by chronic HIV-1 infection but also by acute Sendai virus infection.
RelA (p65) binding activity is induced in response to viral VOL. 67, 1993 infection. For identification of the individual NF-KB proteins associated with the protein-DNA complexes, antisera specific for different NF-KB subunits, NFKB1 (p105 and p5O), NFKB2 (plOO and p52), RelA (p65), and c-rel, were preincubated with PLB cellular extracts, and the products were analyzed by an EMSA (Fig. 2) . In extracts from PMAtreated PLB-985 cells, the disappearance of the NF-KBspecific complex following preincubation with the N-terminus-reactive anti-p1O5 or anti-pSO antiserum ( Fig. 2A, 10) were preincubated with antisera to p50 (lanes 2, 3, 7, and 8) and ReLA (lanes 4, 5, 9, and 10).
was accompanied by the appearance of a shifted slowly migrating complex; the addition of excess peptide used for antibody production inhibited the formation of the shifted complex, thus confirming the specificity of the antibody (Fig.  2A, lane 4) . No shifted complex was obtained with antisera to RelA or other subunits ( Fig. 2A, lanes 5, 7, and 9) ; the same results were obtained with extracts from TNF-atreated PLB-985 cells (data not shown). In most lanes, a weak nonspecific shifted band that was also seen with preimmune serum (Fig. 2A, lane 2) and that was not inhibited by the specific peptides used to prepare the antibodies ( Fig. 2A, lanes 4, 6, 8 , and 10) was observed.
In contrast, shifted complexes corresponding to both p5O 2) and PLB-IIIB (lanes 8 and 9) cells were labelled for 3 h in methionine-free RPMI 1640; proteins were extracted and immunoprecipitated with preimmune serum (lanes 1 and 8) and with anti-IKBa antiserum (lanes 2 and 9). Extracts from PLB-985 (lanes 3 to 7) and PLB-IIIB (lanes 10 to 14) cells were also immunoprecipitated with anti-IKBa antiserum, and the precipitates were collected on protein A-Sepharose beads and extensively washed.
Following boiling in 1% sodium dodecyl sulfate-0.5% P-mercaptoethanol, the initial precipitates were reprecipitated with antisera to IKBa (lanes 3 and 10), RelA (lanes 4 and 11), NFKB1 (p105 or p50) (lanes 5 and 12), and NFKB2 (lyt-10, plO0, or p52) (lanes 6 and 13) and with preimmune (PI) serum (lanes 7 and 14) . The positions of molecular mass markers are indicated (in kilodaltons); the arrows indicate RelA (p65) and IKBa. c-rel or NFKB2 (plOO or p52) protein in complex formation was obtained (Fig. 2B, lanes 7 to 10) . Similarly, shifted complexes corresponding to both p5O and RelA subunits were found in extracts from HIV-1-infected PLB-IIIB cells (data not shown). Thus, in myeloblastic PLB-985 cells, NF-KB RelA DNA binding is specifically induced as a consequence of either acute Sendai virus infection or chronic HIV-1 infection. The addition of anti-NFKB1 or anti-RelA antiserum did not result in the complete disappearance of the NF-KB complex, even with titration of the antiserum (data not shown), suggesting that other DNA binding proteins unrelated to NF-KB may be present in the complex.
When the HIV-1 enhancer probe was used, anti-p5O completely inhibited the NF-KB complexes in both PMAand Sendai virus-induced cell extracts and resulted in the formation of a shifted protein-DNA complex (Fig. 2C, lanes  2 and 7) . The addition of the p5O peptide used to produce the antiserum completely blocked the shift (Fig. 2C, lanes 3 and  8) . Again, NF-KB RelA DNA binding was stimulated only in virus-infected cells (Fig. 2C, lane 9) . Anti-RelA antiserum resulted in the specific disappearance of the uppermost protein-DNA complex; the addition of RelA peptide restored the uppermost NF-KB complex (Fig. 2C, lane 10) . Since the upper complex also disappeared when anti-p5O antiserum was included in the reactions (Fig. 2C, lane 7) , this complex represents a p5O-ReIA heterodimer. These data indicate that the proteins associated with the HIV-1 enhancer probe were mainly ReLA and p50, whereas the P2 probe interacted with ReLA and p50 as well as other proteins.
Immunoprecipitation (Fig. 4, lanes 1 to 3) ; however, complexes induced in response to TNF-ot (Fig. 4, lanes 4 to 6) or PMA (data not shown) treatment resolved into two major proteins, of 40 and 50 kDa, and a minor protein, of 70 kDa (Fig. 4, lane 4) . These proteins could be inhibited through competition by an excess of either P2 or HIV-1 oligonucleotide (Fig. 4, lanes 5 and 6) . In contrast, the DNA binding complex constitutively present in PLB-IIIB cells (55) and in Sendai virus-induced PLB-985 cells resolved into three proteins, of 70, 90, and 100 kDa (Fig. 4, lanes 7 to 10) . These proteins exhibited a high degree of specificity for P2 and were inhibited through competition by an excess of unlabeled P2 probe (Fig. 4, lanes 9 and 13) but not the HIV-1 enhancer probe (Fig. 4, lanes 8 and 12) . The 70-kDa protein was induced by TNF-a in HIV-1-infected cells (Fig. 4, compare lanes 7 and 11) , and its binding was specifically inhibited by the addition of IKBBa (data not shown). The 70-kDa protein therefore appears to be the NF-KB RelA (p65) subunit. Thus, distinct proteins with specificity for the P2 NF-KB site appear to be induced by either HIV-1 or Sendai virus infection of PLB-985 cells.
Specific binding to an AT-rich oligonucleotide. The P2 NF-KB site differs from the HIV-1 enhancer NF-KB site by only 2 bases, at positions 5 and 6, resulting in a 5-bp central AT-rich region. To determine whether virus-inducible complex A could bind to such an AT-rich site, cellular extracts from TNF-a-induced PLB-985 (Fig. 5, lanes 1 to 4) and PLB-IIIB (Fig. 5 , lanes 5 to 8) cells were incubated with a radiolabelled AT-rich probe, either alone or with competitor DNA. Interestingly, binding to the AT-rich probe was detected only in virus-infected cells (Fig. 5, lanes 1 and 4) ; the AT binding activity was specifically inhibited by the addition of excess P2 (Fig. 5, lane 7) or AT-rich (Fig. 5, lane 8) oligonucleotide but not HIV-1 oligonucleotide (Fig. 5, lane  6) . The same AT binding complex was also generated in extracts from Sendai virus-infected PLB-985 cells (data not shown). For determination of which proteins were involved in binding to this AT-rich region, competition analysis revealed that only the 90-to 100-kDa proteins could be specifically inhibited through competition by the addition of excess unlabelled AT-rich oligonucleotide (Fig. 4, lanes 10  and 14) . This unique binding specificity of the 90-to 100-kDa 6) . rIKBa inhibited the TNF-ot-induced NF-KB complexes in PLB-985 cells (Fig. 6 , lane 2) but only partially decreased the level of complex A in PLB-IIIB cells (Fig. 6, lane 4) . The protein-DNA complex formed with the AT-rich probe and extracts from PLB-IIIB cells (Fig. 6 , lane 5) also was not inhibited by the addition of rIKBa (Fig. 6, lane 6 ). This result also indicates that virus-induced complex A was not regulated by IKBa and may not be an NF-KB-related complex.
Tryptic digestion analysis of proteins binding to P2. Previous studies demonstrated that NF-KB p5O had a trypsinresistant core that maintained DNA binding specificity (3) . To eliminate the possibility that the UV cross-linked 90-to 100-kDa adducts were p50 homodimers irreversibly bound to the probe and as an additional test of the NF-KB relatedness of the AT-rich binding 90-to 100-kDa proteins, tryptic digestion analysis of the different complexes was performed (Fig. 7) . Recombinant p50 and extracts from TNF-a-treated PLB-985 and PLB-IIIB cells were digested with trypsin for 1 to 30 min and then analyzed for DNA binding activity to P2 (Fig. 7, lanes 1 to 15) and AT-rich (Fig. 7, lanes 16 to 20) probes. Purified recombinant p50 was reduced to a trypsinresistant core in about 4 min (Fig. 7, lanes 1 to 5) , whereas the complexes from TNF-a-treated PLB-985 cells (Fig. 7 , lanes 6 to 10) were degraded more slowly but also generated the trypsin-resistant core. Interestingly, complexes from TNF-a-treated PLB-IIIB cells had trypsin-sensitive and trypsin-resistant components (Fig. 7, lanes 11 to 15) , consistent with the fact that a portion of these complexes corresponds to NF-KB and a portion corresponds to the 90-to 100-kDa species. The protein complex that was from virusinfected cells and that specifically bound to AT-rich DNA was completely trypsin resistant (Fig. 7, lanes 16 to 20) . As summarized in Table 1 , the 90-to 100-kDa proteins observed in chronically HIV-1-infected PLB-IIIB cells or in Sendai virus-infected PLB-985 cells possessed a number of features that distinguished them from the NF-KB-specific complexes observed in TNF-a-or PMA-induced PLB-985 cells.
Expression of NF-KB-dependent plasmids in PLB cells. To 100-kDa proteins associated with either the P2 or the ATrich probe were not inhibited by the addition of excess rIKBa. Second, the formation of the 90-to 100-kDa protein complex with the P2 or the AT-rich probe was not blocked in the presence of several different NF-KB subunit-specific antisera. Third, the virus-induced 90-to 100-kDa protein complex was trypsin resistant, whereas recombinant p50 or p50-RelA from cell extracts was trypsin sensitive. The protein complex binding to the AT probe was also trypsin resistant. On the basis of the unique sequence specificity of the 90-to 100-kDa protein complex, the inability of IKBct to block DNA binding, and the trypsin resistance of the complex, these proteins do not appear to be NF-KB related.
One possibility is that the 90-to 100-kDa proteins are related to other transcription factors that bind AT-rich sequences or to the chromosome-associated HMG I/Y proteins, which have been shown to interact with the PRDII domain (65) . HMG a 8
inhibition by IKBa, inability to be stimulated by deoxycholate treatment, distinct tryptic digestion products, and lack of reactivity to antisera against p50, v-rel, or c-rel (36) .
The level of expression of this factor was high in pre-B and immature T cells and was thought to be involved in lymphocytic development (36) . The biochemical identity of these proteins, as well as a comparison with the 90-to 100-kDa proteins, will require further analysis. Distinct combinations of NF-KB binding proteins contribute to differential gene activation (5, 28, 33, 35, 48, (68) (69) (70) . In vitro transcription experiments demonstrated that NFKB1 (p50) homodimers stimulated transcription from a template controlled by the immunoglobulin K element but not by the PRDII element, whereas RelA homodimers or NFKB1-RelA heterodimers stimulated in vitro transcription from both the immunoglobulin K and the PRDII templates by 10-fold. Conformational differences may contribute to the degree of transcriptional activation by different subunit combinations (16) . These results are consistent with those of cotransfection studies demonstrating that NF-KB heterodimer combinations are transcriptionally more potent than p50 homodimers (48, 61) .
With regard to HIV-1 infection, an increase in transcriptionally active NF-KB DNA binding complexes in general and constitutive posttranslational induction of RelA in particular appears to provide an intranuclear environment that maintains a high level of HIV-1 LTR-mediated gene expression. Enhanced HIV-1 replication in myeloid cells may activate other NF-KB-regulated cytokine genes, including TNF, IL-1, IL-2, IL-6, and GM-CSF (49) . In addition to an autostimulatory effect on HIV-1 replication and NF-KB induction, cytokine induction may produce a range of pleiotropic effects in the host, including inflammation, fever, and cachexia (54) . The constitutive activation of specific members of the NF-KB/rel family of transcription proteins may thus contribute to the pathogenesis of HIV-1 infection in myeloid cells.
